Brief report · 30 Jun 2026
Conference abstractPublished 6 Dec 2017
Cu(II) complexes of tridentate Schiff base ligand: Synthesis, characterization and biological evaluations
Vaal University of Technology, South Africa
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Tridentate donor ligands have shown some ability to stabilize metal complexes, with coordination taking place through the nitrogen-oxygen donor atoms. Schiff bases of aldehydes, their derivatives, and transition metal complexes are active as anticancer, antimicrobial and antioxidative agents. Schiff bases are considered very important class of organic ligands possessing wide applications in many biological aspects. Antioxidants derived from metal-Schiff base ligand combinations have received current attention for their capability to safeguard cells from impairment caused by free radicals. This study aims at the synthesis, characterization of Cu(II) complexes bearing NNO-ligand, antiradical and antimicrobial potentials of the compounds. The synthesized compounds were coloured, air stable and characterized spectroscopically using elemental analyses, molar conductance, UV-Vis, FT-IR, and NMR. The spectral data suggest that the ligand act as tridentate chelating compound, coordinating to the copper ions via the two nitrogen atoms of the azomethine group as well as O atom of phenolic group of the 2',4'-dihydroxyacetophenone. Conductance measurements indicated that the complexes are non-electrolytes. Square planar geometry was proposed for the Cu(II) complexes bearing different anions: Cl , Br-, SCN-, NO3-, CH3CHOO. The in vitro antioxidant activity indicated that the compounds are capable of scavenging DPPH, ABTS radicals in a dose-dependent pattern, with an IC50 order higher than the free ligand. Antimicrobial screening against strains gave a low to high activities in the order: SCN- > Cl > Br- > NO3- > CH3CHOO- > Ligand. The results showed that the compounds could be a good source of chemotherapeutic agent precursors for infectious disease control.
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Medicinal Chemistry.
Commentary · 29 Dec 2025
Accelerating Drug Discovery: Molecular Docking and Virtual Screening
Opinion · 29 Dec 2025
Pharmacophore Modeling: A Cornerstone of Drug Discovery
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedicinal Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Ikechukwu P Ejidike”
- BylineArticles whose byline prints “Fanyana M Mtunzi”
